Cliff Asness's INMB Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 270,317 shares of INmune Bio Inc. (INMB) worth $305,458, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in INMB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 249,798 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's INmune Bio (INMB) Holding Value Over Time
Track share changes against reported price movement
Quarterly INmune Bio (INMB) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +249,798 | Add 1217.40% | 270,317 | $1.13 |
| Q4 2025 | +213 | Add 1.05% | 20,519 | $1.56 |
| Q3 2025 | +20,306 | New Buy | 20,306 | $2.07 |
Cliff Asness's INmune Bio Investment FAQs
Cliff Asness first purchased INmune Bio Inc. (INMB) in Q3 2025, acquiring 20,306 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held INmune Bio Inc. (INMB) for 3 quarters since Q3 2025.
Cliff Asness's largest addition to INmune Bio Inc. (INMB) was in Q1 2026, adding 270,317 shares worth $305,458.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 270,317 shares of INmune Bio Inc. (INMB), valued at approximately $305,458.
As of the Q1 2026 filing, INmune Bio Inc. (INMB) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in INmune Bio Inc. (INMB) was 270,317 shares, as reported at the end of Q1 2026.